High-Content Monitoring of Drug Effects in a 3D Spheroid Model
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
A recent decline in the discovery of novel medications challenges the widespread use of 2D monolayer cell assays in the drug discovery process. As a result, the need for more appropriate cellular models of human physiology and disease has renewed the interest in spheroid 3D culture as a pertinent model for drug screening. However, despite technological progress that has significantly simplified spheroid production and analysis, the seeming complexity of the 3D approach has delayed its adoption in many laboratories. The present report demonstrates that the use of a spheroid model may be straightforward and can provide information that is not directly available with a standard 2D approach. We describe a cost-efficient method that allows for the production of an array of uniform spheroids, their staining with vital dyes, real-time monitoring of drug effects, and an ATP-endpoint assay, all in the same 96-well U-bottom plate. To demonstrate the method performance, we analyzed the effect of the preclinical anticancer drug MLN4924 on spheroids formed by VCaP and LNCaP prostate cancer cells. The drug has different outcomes in these cell lines, varying from cell cycle arrest and protective dormancy to senescence and apoptosis. We demonstrate that by using high-content analysis of spheroid arrays, the effect of the drug can be described as a series of EC50 values that clearly dissect the cytostatic and cytotoxic drug actions. The method was further evaluated using four standard cancer chemotherapeutics with different mechanisms of action, and the effect of each drug is described as a unique multi-EC50 diagram. Once fully validated in a wider range of conditions, this method could be particularly valuable for phenotype-based drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 2×
“Tissue Eng Part C Methods (2015) 21(8):852–61.”
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981 · cited 5×
“Biotechnol Bioeng (2003) 83(2):173–80.”
InfluentialSpheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 6×
“Assay Drug Dev Technol (2016) 14(7):367–80.”
InfluentialOrgans-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185 · cited 3×
“J Cancer Res Clin Oncol (2016) 142(9):1955–66.”
BackgroundZanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024 · cited 10×
“The optimal conditions required to form spheroids of approximately 400 μm in diameter (21, 31, 83) were determined to be 2,000 cells/well for 7 days with VCaP cells.”
BackgroundMethodInfluentialThree-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
IMAMURA, Y., MUKOHARA, T., SHIMONO, Y., FUNAKOSHI, Y., CHAYAHARA, N., TOYODA, M., KIYOTA, N., TAKAO, S., KONO, S., NAKATSURA, T., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3767 · Cited by 845 · cited 6×
“Probe Localization assay type ex/em Method Reference Hoechst 33342 Nucleus/DNA Nuclei staining 350/461 HD, NAC, SFM, ULA (20, 23, 47–53) DRAQ5 Nucleus/DNA Nuclei staining 647/665 HD, SFM (54, 55) SYTO11 Nucleus/DNA Nuclei staining 508/527 HD, ULA (52) Propidium iodide Nucleus/DNA Viability/cytotoxicity 538/617 SFM, UL…”
InfluentialScreening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525 · cited 5×
“In recent years, significant efforts have been made to implement 3D models in drug discovery protocols (1, 101, 104).”
BackgroundInfluentialObservations of the living developing nerve fiber
Harrison, R. G., Greenman, M. J., Mall, F. P., & Jackson, C. M. (1907) · The Anatomical Record · doi:10.1002/ar.1090010503 · Cited by 515 · cited 1×
“Spheroid culture is as old as cell culture itself (14, 15): the first pioneer that worked with cell cultures previously documented that “groups of cells round themselves off into little spheres” (16).”
BackgroundThe discovery of first-in-class drugs: origins and evolution
Eder, J., Sedrani, R., & Wiesmann, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4336 · Cited by 514
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512 · cited 2×
“ACS Biomater Sci Eng (2015) 1(10):877–94.”
BackgroundPhenotypic screening in cancer drug discovery — past, present and future
Moffat, J. G., Rudolph, J., & Bailey, D. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4366 · Cited by 507
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Human tissues in a dish: The research and ethical implications of organoid technology
Bredenoord, A. L., Clevers, H., & Knoblich, J. A. (2017) · Science · doi:10.1126/science.aaf9414 · Cited by 334 · cited 1×
“In Vitro Cell Dev Biol Anim (1997) 33(6):459–66.”
Stock, K., Estrada, M. F., Vidic, S., Gjerde, K., Rudisch, A., Santo, V. E., Barbier, M., Blom, S., Arundkar, S. C., Selvam, I., et al. (2016) · Scientific Reports · doi:10.1038/srep28951 · Cited by 253
Yip, D., & Cho, C. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.008 · Cited by 236
A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay
Friedrich, J., Eder, W., Castaneda, J., Doss, M., Huber, E., Ebner, R., & Kunz-Schughart, L. A. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107306839 · Cited by 227 · cited 1×
“, MTT tetrazolium reduction (81) and acid phosphatase assay [APH (22, 82)], use colorimetry, while others are based on fluorescence [Resazurin reduction (83, 84)] or chemiluminescence [ATP assay (85)].”
MethodHo, W. Y., Yeap, S. K., Ho, C. L., Rahim, R. A., & Alitheen, N. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044640 · Cited by 173 · cited 1×
“, MTT tetrazolium reduction (81) and acid phosphatase assay [APH (22, 82)], use colorimetry, while others are based on fluorescence [Resazurin reduction (83, 84)] or chemiluminescence [ATP assay (85)].”
MethodJedrzejczak-Silicka, M. (2017) · New Insights into Cell Culture Technology · doi:10.5772/66905 · Cited by 87
Toward the broad adoption of 3D tumor models in the cancer drug pipeline
Cox, M. C., Reese, L. M., Bickford, L. R., & Verbridge, S. S. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00172 · Cited by 80
Solomon, M. A., Lemera, J., & D’Souza, G. G. M. (2016) · Journal of Liposome Research · doi:10.3109/08982104.2015.1105820 · Cited by 30
Imaging Cellular Spheroids with a Single (Selective) Plane Illumination Microscope
Swoger, J., Pampaloni, F., & Stelzer, E. H. K. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot080176 · Cited by 13 · cited 6×
“Probe Localization assay type ex/em Method Reference Hoechst 33342 Nucleus/DNA Nuclei staining 350/461 HD, NAC, SFM, ULA (20, 23, 47–53) DRAQ5 Nucleus/DNA Nuclei staining 647/665 HD, SFM (54, 55) SYTO11 Nucleus/DNA Nuclei staining 508/527 HD, ULA (52) Propidium iodide Nucleus/DNA Viability/cytotoxicity 538/617 SFM, UL…”
Influential
Cited by
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
Theard, P. L., Sheffels, E., Sealover, N. E., Linke, A. J., Pratico, D. J., & Kortum, R. L. (2020) · eLife · doi:10.7554/elife.58204 · Cited by 69
“In the current study, we use ultra-low attachment plates of monoculture NSCLC cell lines as these have the advantage of recapitulating in vivo findings while allowing for dose-response studies done at scale (Mittler et al., 2017).”
MethodNon-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
Luan, Q., Becker, J. H., Macaraniag, C., Massad, M. G., Zhou, J., Shimamura, T., & Papautsky, I. (2022) · Lab on a Chip · doi:10.1039/d2lc00244b · Cited by 45
Metadata
- Authors
- Mittler, F., Obeïd, P., Rulina, A. V., Haguet, V., Gidrol, X., & Balakirev, M. Y.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2017-12-11
- Volume
- 7
- Pages
- 293-293
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2772195672
- Cited by
- 194
- References
- 27
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.